Skip to main content

Eserine

  • Chapter
  • First Online:
Natural Small Molecule Drugs from Plants

Abstract

Eserine is an alkaloid extracted from Physostigma venenosum, which is a reversible acetylcholinesterase (AChE) inhibitor. Eserine is the same as acetylcholine, which can combine with cholinesterase, while AChE inhibitor will combine more tightly with cholinesterase, which leads to slow hydrolysis, inactive enzyme, cumulative ACh, and emergent biological activities. Eserine is employed clinically to treat glaucoma. Compared with pilocarpine, it is provided with shorter effective time and stronger effect; meanwhile it is more provocative and poorly tolerated, so it is most often used to locally treat acute glaucoma. For eserine is toxic, unstable, and unsafe, it is only used early in ophthalmology. With the expansion of its applications and the development of analytic techniques, researchers got over some barriers, and the studies about eserine were taken more seriously in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. QE JI. Progress on mechanism and supersession of physostigmine. Foreign Med Sci Sect Pharm. 1993;20(4):201–3.

    Google Scholar 

  2. Zhou YY. Review of the synthesis of physostigmine. J Yunnan National Univ. 2015;24(3):165–75.

    Google Scholar 

  3. Proudfoot A. The early toxicology of physostigmine. Toxicol Rev. 2006;25(2):99–138.

    Article  CAS  Google Scholar 

  4. Run GY. The development history of natural medicine transform to chemical medicine. Heilongjiang: Heilongjiang University of Chinese Medicine; 2013.

    Google Scholar 

  5. Yang SJ. Pharmacology. Beijing: People’s Medical Publishing House; 2012.

    Google Scholar 

  6. Boyer AW, Somani SM. Pharmacokinetics of biliary excretion of physostigmine in rat. Arch Int Pharmacodyn Ther. 1986;278(2):180–92.

    Google Scholar 

  7. Walter K, Muller M, Barkworth MF, et al. Pharmacokinetics of physostigmine in man following a single application of a transdermal system. Br J Clin Pharmacol. 1995;39(1):59–63.

    Article  CAS  Google Scholar 

  8. Meuret P, Backman SB, Bonhomme V, et al. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology. 2000;93(3):708–17.

    Article  CAS  Google Scholar 

  9. Kirrane RM, Mitropoulou V, Nunn M, et al. Physostigmine and cognition in schizotypal personality disorder. Schizophr Res. 2001;48(1):1–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guan-Hua Du .

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lin, YH., Fang, LH., Du, GH. (2018). Eserine. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_41

Download citation

Publish with us

Policies and ethics